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Here, we report a widely and generally applicable
strategy to obtain reliable information in high-
throughput protein screenings of enzyme mutant
libraries. The method is based on the usage of the
split-GFP technology for the normalization of the
expression level of each individual protein variant
combined with activity measurements, thus
resolving the important problems associated with
the different solubility of each mutant and allowing
the detection of previously invisible variants. The
small size of the employed protein tag (16 amino
acids) required for the reconstitution of the GFP fluo-
rescence reduces possible interferences such as
enzyme activity variations or solubility disturbances
to a minimum. Specific enzyme activity measure-
ments without purification, in situ soluble protein
expression monitoring, and data normalization are
the powerful outputs of this methodology, thus
enabling the accurate identification of improved pro-
tein variants during high-throughput screening by
substantially reducing the occurrence of false nega-
tives and false positives.
INTRODUCTION
Modern protein engineering is mainly based on the generation of
mutational diversity libraries and their further screening in the
search for protein variants exhibiting the desired properties (i.e.
stability, altered substrate scope, or catalytic activity improve-
ment) (Bornscheuer et al., 2012). Despite the large number of
molecular biology methods that have been developed to
generate the desired library (Ruff et al., 2013), the screening
phase still constitutes a major challenge, especially when the
exploration of wide mutational landscapes (i.e. those generated
by randommutagenesis or by multiple-position saturation muta-
genesis) is required (Romero and Arnold, 2009). Since only in
particular cases the analysis of millions of variants is possible1406 Chemistry & Biology 22, 1406–1414, October 22, 2015 ª2015 Eby solid-phase assays, fluorescence-activated cell sorting, or
microfluidic approaches (Theberge et al., 2010; Weib et al.,
2014; Yang andWithers, 2009), library screenings are commonly
performed by the much more flexible analysis of individual
clones cultured in 96- or 384-well plates, thus limiting the number
of analyzed variants to a few thousands per week even in the
best of cases, when an automated robotic platform is available.
Furthermore, many concurrent factors can lead to the generation
of false-positive and false-negative putative hits during the
screening of the libraries, making experimental efforts much
more complex, and time- and material-consuming. Some of
these problematic factors, such as uneven growth of the clones
placed in different wells, are basically technical issues that can
be partially overpassed by the implementation of certain mea-
sures in the protocol and improved equipment. However, other
factors are completely beyond our control, the solubility and
expression level of each particular mutant being by far the
most challenging one (Taverna and Goldstein, 2002). Even single
mutations can alter both the solubility and the activity of a pro-
tein, but quite often already in a double mutant one of the amino
acid changes determines an improvement in the desired biolog-
ical activity while the other decreases the solubility. If the magni-
tude of the activity improvement compared with the wild-type
protein cannot compensate the solubility drop, that valuable
mutant will remain undetectable as a hit in a standard screening
procedure, as commonly only total activity in the crude extract is
measured. For the same reasons, mutations that increase the
solubility or the expression level of the protein (even when being
desirable) can generate false positives in the search for improved
specific activities. Normally, false positives are discarded after
the tedious manual purification and characterization of each po-
tential hit, but false negatives are simply drained into the waste
day after day in every protein engineering laboratory. Since the
likelihood of combining amino acid changes that increase the
specific activity while being neutral or favorable with respect to
the solubility in a multiple mutant is quite low (as most of the
mutations negatively affect these aspects) (Romero and Arnold,
2009; Taverna and Goldstein, 2002), protein engineers are
forced to perform the screening of extremely large libraries in
the search for true hits.
In this study, we present an almost universal approach
to overcome all these limitations in a fast, affordable, andlsevier Ltd All rights reserved
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Figure 1. Work Flow of the In-Depth
Screening Methodology
Step 1: The standard screening approaches are
limited to the measurement of the total enzymatic
activity (represented as a red line) present in the
crude cell extracts of each individual expression
clones. Step 2: The quantification of the real
amount of soluble protein for each variant is
possible through the split-GFP technology. The
different color intensity shown for the green spots
represents the different level of soluble protein
expression for each well. Step 3: The normalization
of the enzymatic activity data with respect to the
protein content for each well reveals previously
invisible potential hits, represented as red spots.
Step 4: The potential hits selected during the
normalized screening are replicated in a confir-
mation plate for an accurate evaluation of the
results.technically simple manner. In brief, the system consists in use
of a 16-amino-acid residues tag (GFP11) that complements
a truncated GFP (GFP 1–10), resulting in the regeneration of
the fluorescent GFP signal. The measurement of this fluores-
cence provides the quantification of the soluble protein con-
tent (Cabantous et al., 2005; Cabantous and Waldo, 2006)
required for the normalization of the activity assays. This
methodology is extremely flexible, and helps the researcher
to discard false positives and identify commonly invisible false
negatives while providing valuable information about the sol-
ubility of each protein variant, all in a single step, thus consid-
erably reducing the screening effort normally required to find
improved hits.
RESULTS
Design of a General Strategy for the Normalized
Screening of Protein Engineering Mutant Libraries
The GFP11 tag can be added to the N or C terminus of the pro-
tein of interest, or even as an internal tag if a flexible loop is
exposed. To overpass any kind of vector or restriction site lim-
itation, we recommend tagging the gene of interest by simplyChemistry & Biology 22, 1406–1414, October 22, 2015using two consecutive PCR steps (see
Figure S1). In our experience, all the pro-
teins that were originally able to accept a
terminal His6 tag could also carry a
consecutive functional GFP11 tag while
retaining their enzymatic activity and
solubility. We have tested the GFP11-
tagging acceptance with satisfactory re-
sults for the homodimeric Vibrio fluvialis
transaminase (Nobili et al., 2015) (VFTA)
(with a C-terminal GFP11 tag, preserving
77% of the original activity), the cyclo-
hexanone Baeyer-Villiger monooxyge-
nase from Acinetobacter sp. (Schmidt
et al., 2015) (CHMO) (C-terminal tagging,
94%), and pig-liver esterase isoenzyme 3
(Hummel et al., 2007) (PLE3) (N-terminaltagging, 71%), thus illustrating its potential flexibility (Figure S2).
The subsequent strategy for the normalized screening of the
GFP11-tagged libraries is illustrated in Figure 1. Basically, a
split-GFP-based protein quantification (Cabantous and Waldo,
2006) for each 96-well plate is paired with the corresponding
activity assay (Donoghue et al., 1976; Krebsfa¨nger et al.,
1998; Schaetzle et al., 2009) (see Figures S3–S5), and the ratio
between the activity slope and the fluorescence value (Ra/f) is
calculated for each individual well. Since every plate contains
four replicates of the original wild-type variant of the protein
(wt), it is easy to compare the Ra/f of the different mutants
with these references. Thus, it is possible to overcome the
deviation caused by the different protein expression levels of
each variant and to perform a more accurate data evaluation
that will allow us to mine previously invisible library features.
In our experience an Ra/f value higher than any of the four
wild-type references was the most useful criterion to establish
a detection threshold for true hits. In addition, we highly recom-
mend another four wells containing an empty vector (i.e. without
any GFP11-tagged protein and without biological activity in the
screening assay) for background subtractions to increase the
accuracy of the calculations.ª2015 Elsevier Ltd All rights reserved 1407
Analysis of a Single Clone 96-Well Plate Illustrates the
Noise Reduction Achieved by the Normalization
Procedure
To check the accuracy of our data normalization methodology,
we performed a high-stringency test, based on the analysis of
a single 96-well plate containing the same Escherichia coli
BL21 transformed clone (overexpressing a unique protein
variant, VFTAwt-GFP11, see Experimental Procedures) pipetted
into each well from the same homogeneous starting culture (to
eliminate any kind of initial inoculation deviation, initial OD600 =
0.05), grown for 6 hr and afterward induced for 12 hr. Figure 2
shows 3D plots representing culture growth (Figure 2A), enzy-
matic activity slopes (employing (S)-1-phenylpropan-1-amine
[PPA] as substrate, see Supplemental Information) (Figure 2B),
the VFTA protein content calculated via the split-GFP fluorescent
measurement (Figure 2C), and their respective activity/fluores-
cence ratio (Figure 2D) for every well in the plate. The data
smoothness achieved by the ratio calculation is evident, and it
is statistically reflected as a reduction of the relative SD (RSD)
among the wells: 10.88% with respect to the mean in the case
of the protein content measured as reconstituted split-GFP fluo-
rescence, 10.23% for the enzymatic activity slopes, and only
6.96% for their ratios. Our normalization procedure also reduced
substantially the differences in the case of the most extreme
values of each data distribution (64% for the fluorescence,
58% for the enzymatic activity slopes, and 41% for their ratio).
These results clearly point out two facts: first, that even with
extremely similar starting conditions there is a considerable
intrinsic variation in the protein expression levels in the different
wells; and second, that the normalization of the activity present
in each crude extract respect to its particular protein content
constitutes a more accurate tool than the traditional simple anal-
ysis of the total enzymatic activity detected. In other words, the
normalization improves the separation band between wild-type
and hit values (Zhang et al., 1999). This apparently modest
achievement will become a crucial feature during the analysis
of real protein engineering libraries whereby each variant shows
a completely different solubility, as described below.
Proof of Principle: The Normalized Analysis of a VFTA
Error-Prone PCR Small Library Reveals the Potential of
the Method to Identify False-Negative Clones
Our initial hypothesis claimed the existence ofmore potential hits
in protein engineering libraries than the ones we can discover
without normalization. To probe this, we produced an error-
prone PCR (epPCR) library from our GFP11-tagged version of
VFTA (with an average of 3.7 ± 1.1 mutations per gene) employ-
ing MEGAWHOP (Miyazaki, 2011), and the screening of a small
number (588) of clones in the acceptance of PPA as substrate
(see Supplemental Information) was performed. The enormous
solubility differences exhibited by the different mutants can be
observed in Figure 3 (compare with Figure 2). The Ra/f for every
individual clone and the search for positive hits were calculated
employing the R scripts (see Supplemental Information) to select
only protein variants that have an Ra/f 20% better than any of the
wild-types, a threshold approximately three times better than the
fluctuations measured for a single clone multiply grown under
optimal conditions (Figure 2). The normalization scripts automat-
ically generate graphs like the ones shown in Figures 4 and S5,1408 Chemistry & Biology 22, 1406–1414, October 22, 2015 ª2015 Ecomprising a high amount of information about each protein
variant and permitting rapid identification of the interesting mu-
tants present in the library. For every 96-well plate, the wild-
type references were placed in well positions A1, B1, C1, and
D1. This first analysis allowed us to identify a number of putative
hits showing a potential improvement in the Ra/f for PPA. The
plasmids contained in those clones were purified and trans-
formed again into E. coli BL21 (DE3). For each plasmid, four of
the new clones were picked into the confirmation plate (Figure 1)
to evaluate the reproducibility of the results. Although the anal-
ysis of these replicates showed that most of the putative hits
did not exhibit a consistent improvement of the Ra/f compared
with VFTAwt-GFP11 (and were revealed as wild-type back-
ground after sequencing), one of them did show a clearly
increased Ra/f when employing PPA as substrate. That variant
contained four point mutations, from which three were silent
and the fourth was determined as an F85L substitution. Strik-
ingly, that particular mutant would never have been detected in
the error-prone library without the split-GFP protein content
normalization, as its activity slope was smaller than the ones cor-
responding to the wild-type reference wells (Figure 4) while only
Ra/f ratio comparison allowed its rescue from the library.
Recently, the same F85L VFTA variant, encoded by a different
codon, has been independently reported by our group via a
semi-rational mutational approach and a standard activity
screening (Nobili et al., 2015), showing almost exactly the
same specific activity improvement (50%) with respect to the
VFTAwt as we have determined in the analysis of our GFP11-
tagged library, thus validating the robustness of our method
(Figure 5). The enzymatic activity measured for the four repli-
cates of the F85L mutant showed an RSD of 6.1% that was
reduced to only 2.9% after the Ra/f normalization.
In addition, during the screening of the same library we were
able to identify a VFTA variant showing improved (32%) expres-
sion levels in E. coli BL21 (Figures 5 and S5), bearing a N314I
mutation together with two additional silent mutations. This
result occurred simultaneously with the discovery of the activ-
ity-improved F85L mutant, and shows the importance of the
additional information provided by the evaluation of the protein
content, even beyond the activity normalization.
DISCUSSION
We have shown how protein content normalization can expand
the possibilities and accuracy of traditional protein engineering
screenings by providing additional information about each pro-
tein variant, and how the split-GFP technology allows such per-
formance of such normalization in a fast, easy, flexible, and
affordable manner. Advantages with respect to the use of whole
GFP-fused proteins are obvious: the small size of the GFP11 tag
reduces the likelihood of substantial folding and/or activity dis-
turbances of the original target protein, while a fused whole
GFP protein can interfere many times due to steric hindrance
effects, which are especially common in the case of proteins
requiring multimerization interphases. In addition, when the in-
terest lies in how certain mutations affect the soluble expression
levels of a given protein, the high solubility of the whole GFP can
act as a molecular life jacket, being able to disturb the solubility
of the proteins (Cabantous et al., 2005), and, even when thatlsevier Ltd All rights reserved
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Figure 3. Protein Expression Levels Show a High Heterogeneity in epPCR Mutant Libraries
The 3D plot represents the fluorescence measurements for different VFTA-GFP11 variants expressed in a 96-well plate during our screening process. Right:
Fluorescence histogram, in which the values on the x axis refer to the fluorescence related to the mean fluorescence for the whole plate, thus showing the data
dispersion.approach has succeeded in particular cases (van den Berg et al.,
2006), fusion of proteins cannot be widely employed.
Since our two-step PCR tagging strategy allows a consider-
ably improved flexibility compared with the suitable expression
vectors in relation to availability of restriction sites, protein
linkers, and GFP11 tag positioning (Cabantous and Waldo,
2006), any research group should be able to implement the
method in a fewweeks and immediately afterward start perform-
ing in-depth protein engineering screenings. Even when E. coli is
by far the most common host for the expression of protein li-
braries, the GFP11 tagging can be adapted to any kind of heter-
ologous expression platform, and employed at any imaginable
scale, from massive robotic screening to small single-residue
saturation libraries. Regarding the use of our approach for the
screening of yeast-expressed proteins exported via the secre-
tory pathway, there is in principle no reason to think that the
GFP11 tag could be incompatible with the yeast translocation
system, as other small flexible tags have been successfully em-
ployed before. In fact, the GFP11 tag has been previously used
for the detection of transmembrane proteins in plant, yeast,
and animal cells (Hyun et al., 2015; Rogers and Rose, 2014).
As the translocation mechanisms required for protein secretion
and transmembrane protein expression are similar, it can be
reasonably assumed that the GFP11 tagging would not consti-
tute a problem for the heterologous expression and secretion
of proteins in yeast. Our research is focused in the improvement
of industrially relevant enzymes, but the same principles are
applicable to every conceivable kind of protein, on the only con-
dition that it is able to accept the small GFP11 tag in any position
while retaining its activity. In principle, if the scaffold protein is
able to accept a small purification tag (for example, a His6 tag)Figure 2. Split-GFP Direct Cell Crude Extra Normalization Allows an A
Here, VFTAwt-GFP11 was employed as enzymatic model.
(A) Left: 3D plot of the 96-well plate culture growth over time. Different colors (fro
representing the growth among the wells. The high homogeneity achieved can b
(B) Left: Activity data obtained for each crude extract in the enzymatic assay usi
(C) Left: Relative fluorescence units measured via the split-GFP technology for e
(D) Left: Ra/f calculated for each well. Right: histogram for the Ra/f values. As ca
fluorescence balances the original estimation of the enzymatic activity among th
mean value to give a more accurate idea of the real data dispersion.
1410 Chemistry & Biology 22, 1406–1414, October 22, 2015 ª2015 Ein one of its ends, it is a good idea to place the GFP11 tag just
before or after it, always connected through a flexible linker, so
as to avoid issues related to the interference of the tag with the
protein activity or to the interference of the protein with the
split-GFP reconstitution. Any kind of previous structural informa-
tion about the scaffold protein can be useful in choosing the best
possible positioning for the GFP11 tag.
Split-GFP is an already well-established tool in molecular
biology, and its reliability has been widely tested (Barnard et al.,
2008; Pedelacq et al., 2011), as also illustrated by our results.
However, a considerable portion of the success in the normalized
in-depth screening depends on the selection of the appropriate
threshold criteria for the statistical analysis of the generated
data, as well as on the performance of an optimal background
subtraction. Our analytical scripts, written in the statistics pro-
gramming language R, are designed to provide a flexible tool
for the establishment of the correct thresholds in an easymanner
from the very beginning. The application of the proper criteria for
each particular case will reveal the maximum number of poorly
soluble false-negative mutants carrying interesting mutations
while minimizing the time consumed during the fruitless analysis
of false positives. In general, the careful analysis of the confirma-
tion plate contains the key for a good evaluation of the results, as
consistent Ra/f improvements, even when modest, will normally
be related to interesting mutations. We emphasize that even
when our screening is based on the comparison of the relative
activity of a sample with respect to a reference, the split-GFP
detection system is completely quantitative, as previously shown
(Cabantous et al., 2005; Cabantous and Waldo, 2006), allowing
the direct estimation of the specific activity for each protein
variant if required. The fact that the quantification of the solubleccurate Determination of Relative Protein Activity
m green to red) represent the progression of the cell density. Right: Histogram
e observed.
ng 1 mM PPA and 2.5 mM pyruvate as substrates. Right: Activity histogram.
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lsevier Ltd All rights reserved
A
B
C
D
E
F
G
H
1 2 3 4 5 6 7 8 9 10 11 12
wt
wt
wt
wt
Slope: 0.0363
Fluorescence: 5.37
Ratio: 0.00677
Slope: 0.0282
Fluorescence: 3.26
Ratio: 0.00867
Figure 4. Split-GFP Normalization for In-Depth Protein Engineering Library Screening Correctly Identifies False Negatives that Would Be
Invisible in a Standard Screening
In the generated screening plots, eachwell is represented as a dual graph, which includes the enzymatic activity kinetics of the protein variant (red line) aswell as a
green bar representing the protein fluorescence level. In addition, each individual graph includes the Ra/f calculation for the analyzed variant. The wells corre-
sponding to protein variants showing Ra/f above the established threshold are framed in red. The plate shown in that particular case corresponds to the one
containing the F85L mutant. Left: The graph represents the best wild-type (wt) replicate in this plate with respect to the Rf/a value. Middle: representation of the
screened plate. The red dot indicates the presence of a well expressing a protein variant showing anRf/a value above a certain threshold (20%, in this case). Right:
Graph representing the activity and expression level values for the F85L hit.protein content is performed in parallel with and independently of
theactivity assayguarantees that theactivity normalization is fully
compatible with any kind of traditional screening method or data
treatment in any protein engineering laboratory.
SIGNIFICANCE
Until now the screening of protein engineering mutant
libraries has been usually limited to the measurement of
the total activity provided by each variant, systematically
ignoring the amount of protein responsible for it. This leads
to the waste of interesting, poorly soluble mutants during
everyproteinengineeringscreening focusedon the improve-
ment of enzymatic activities. Here, we show how split-GFP
technology provides an almost universal tool to solve this
problem in a technically simple and affordable manner,
elevating protein engineering library screening to a higher
level of efficiency through the quantification of protein con-
tents and the normalization of their enzymatic activities.
EXPERIMENTAL PROCEDURES
All chemicals andmedia have been purchased fromSigma-Aldrich if not other-
wise mentioned. The bicinchoninic assay was purchased as Pierce BCA Pro-
tein Assay Kit from Life Technologies. Primers were ordered from Invitrogen/
Life Technologies, and microtiter plates (MTPs) from Greiner (96 round wells,
flat bottom, BioOne 655101).
Cultivations weremade in a Thermo Cytomat 1550 incubator, equipped with
a shaking unit. Liquid handling was performed with an Agilent Bravo liquid
handling robot, equipped with a 96-tip pipetting head and 250-ml tips. Optical
density (OD600), fluorescence, and enzyme activity weremeasured in a Thermo
Varioskan MTP reader.
Construction of the GFP11-Tagged Genes for the Normalized
Screening of Enzymatic Activities
Basically the tagging of the target genes was performed by using two consec-
utive PCR steps employing three different primers (Figure S1). The split-GFPChemistry & Biology 22, 1406–1tag consists of a 16-amino-acid sequence (RDHMVLHEYVNAAGIT), which
has been attached to the target protein through a flexible linker (e.g. we
have used the sequence LIGSDGGSGGGSTS). In the case of C-terminal
GFP11 tagging, the GFP11 tag must be followed by a stop codon and the orig-
inal stop codon of the gene must be eliminated, and in the case of N-terminal
tagging, a start codon must precede the GFP11 tag. Thus, the addition of 30
amino acids (90 nucleotides, 93 with the stop codon or the start codon) is
required for the protein tagging. Including a number of nucleotides required
for the annealing with the target gene (15) and a few more required for the
insertion of a restriction site (12), the addition of around 120 nucleotides is
needed for the coupling of the tag to the original gene and subsequent cloning.
The genetic information was split into two overlapping primers (each of around
75 nt length) that are employed in two consecutive high-fidelity PCRs (Fig-
ure S1), using a fixed opposite primer in both steps and employing the gel-
purified product from the first PCR as template for the second one. The final
PCR product, including the GFP11-encoding tag as well as the required start
and stop codons and the chosen restriction sites, can be digested and ligated
into a suitable protein expression vector. Examples with the PCR primers
employed for the tagging and cloning of the target genes studied here (encod-
ing VFTA, CHMO, and PLE3) are shown in Table S1. In these examples, the
final tagged PCR products were cut with NdeI (VFTA) or NcoI (CHMO and
PLE3) and cloned by standard ligation into the pRSFduet vector (Novagen),
previously digested with NdeI and EcoRV (in the case of VFTA) or NcoI and
EcoRV (for PLE3 and CHMO). In the case of PLE3, the elimination of an intra-
genic NcoI site (achieved by point mutation employing the QuikChange
approach, see Table S1 for primers) was required prior to the PCR-based
addition of the GFP11 tag.
Strains and Culture Media
E. coli TOP10 was employed for standard DNAmanipulations and E. coli BL21
(DE3) for heterologous protein expression purposes. Lysogenic Broth (LB) was
employed as routine culture medium and for the heterologous expression of
the VFTA, while Terrific Broth (TB) medium was chosen for the heterologous
expression of PLE3 and CHMO.
Expression, Purification, and Application of the Truncated GFP1–10
Reporter Protein
A detailed protocol for GFP1–10 purification, storage and usage has been
previously established (Cabantous and Waldo, 2006). To develop a faster pu-
rification method, we slightly modified the original purification procedure: the414, October 22, 2015 ª2015 Elsevier Ltd All rights reserved 1411
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Figure 5. Split-GFP Data Normalization in the Confirmation Plates Allows an Accurate Estimation of the Rf/A and the Expression Level
Achieved by Each Individual Protein Variant
Each diagram represents the same screening plate when analyzed on the basis of a different threshold for theRf/a improvement (10%, 30%, 50%, 60%, and 65%)
and the final one (bottom right) represents the evaluation of the expression level of the variants. Red dots represent wells with activity ratios above the established
thresholds, and green dots represent wells showing expression levels above a established fluorescent threshold (20% in this case). Wells marked as ‘‘wt’’ contain
the wild-type variants employed as references, and ‘‘nc’’ wells contain negative control cultures employed for the required background subtractions performed
both for the enzymatic activity and the fluorescence. Each protein variant selected from the original screening 96-well plates has been analyzed as four clustered
replicates, as can be noted because of the consistency of the 50% ratio improved variant, F85L (wells B4–5 and C4–5), and the N314I expression level improved
variant (wells F10–11 and G10–11).isopropyl b-D-1-thiogalactopyranoside (IPTG)-induced cells were centrifuged
for 20 min at 5,000 3 g and the cell pellets were resuspended in 10 ml of TNG
buffer (100 mM Tris-HCl [pH 7.4], 100 mM NaCl, and 10% glycerol) disrupted
by sonication during 5 min. The disrupted cells were centrifuged for 20 min at
5,0003 g and the supernatant was discarded; the resulting GFP1–10 inclusion
bodies pellet was resuspended in 10 ml of TNG buffer, sonicated again for
5 min, and centrifuged (20 min, 5,000 3 g) and the supernatant discarded.
The resuspension, sonication, and centrifugation steps were repeated once
more, and the final supernatant was discarded. The resulting pellet containing
mainly inclusion bodies pellet was weighted and dissolved in 1 ml of 9 M urea
for each 75 mg of inclusion bodies. The resulting solution was divided in 1-ml
fractions in 1.5-ml tubes and centrifuged for 20min at top speed (14,0003 g) in
a microcentrifuge. The supernatant of each tube (1 ml) was transferred to a 50-
ml tube and 25 ml of TNG buffer was added. The final dissolved GFP1–10 pro-
tein was stored in 10-ml fractions at80C until use. For each 96-well plate to
be screened, one of these GFP1–10 tubes was melted on ice and 10 ml of cold
TNG buffer was added, reaching then the 20-ml volume required for the
screening of 96wells. In eachwell, 20 ml of the crude extract sample wasmixed
with 180 ml of theGFP1–10 reporter protein solution. These amounts guarantee
a sufficient excess of the GFP1–10 reporter with respect to the GFP11-tagged
protein. Once both solutions weremixed, the 96-well plates were stored at 4C
for 60–72 hr, the required incubation time for the stabilization of the maximum
fluorescent signal (Figure S3). Even when this procedure allowed us to obtain
repetitive results with excellent sensitivity (see below), the original methodol-
ogy (Cabantous and Waldo, 2006) resulted in higher GFP1–10 yields, which
is reflected in the assay as reaching the maximum fluorescence more rapidly
because of the larger excess of GFP1–10. Thus, because of the relatively small
amount of additional work required in the original protocol, we would recom-
mend users to follow it in caseswhere faster quantification results are required.
The sensitivity and reproducibility of the split-GFP assay was investigated
by measuring the fluorescence in a dilution series of purified VFTAwt-1412 Chemistry & Biology 22, 1406–1414, October 22, 2015 ª2015 EGFP11. The enzyme stock solution used was calibrated by the bicinchoninic
acid assay, applied according to the kit’s standard protocol (Figure S4). A
stock solution of purified VFTAwt-GFP11 (initial concentration. 347.8 ±
23 mg/ml) was diluted ten times. In a series of nine successive steps, this
solution (37.8 ± 2.3 mg/ml) was diluted 1:1 for each step. The fluorescence
for each concentration is plotted in Figure S4 (excitation 488 nm/emission
530 nm).
The split-GFP assay was found to be at least one order of magnitude more
sensitive than the bicinchoninic acid assay (with a detection limit of approxi-
mately 2 mg/ml z 4 pmol/ml of enzyme, which corresponds to 2 pmol of
enzyme per assay, with a molecular weight of 55,236 g/mol for VFTAwt-
GFP11) in cell lysate. The fluorescence measurements usually ranged from
0.9 to 30 Varioskan-RFU, which corresponds to approximately 2–50 mg pro-
tein/ml final assay concentration (and approximately 4–125 pmol protein/
assay). Previous work assessed the detection limit of the split GFP to
0.2 pmol of purified protein per assay (Cabantous et al., 2005).
Heterologous Expression and Purification of the Target Proteins
Shake-Flask Cultivation
LB-Km overnight cultures of E. coli BL21 (DE3) clones containing the desired
constructs (pRSFduet VFTA-GFP11, pRSFduet GFP11-PLE3, or pRSFduet
CHMO-GFP11) were employed as starting inocula (1% volumetric concentra-
tion) for expression cultures (performed in 100 ml of LB for VFTA-GFP11 and
100 ml of TB for GFP11-PLE3 and CHMO-GFP11 in 500-ml flasks). These
expression cultures were grown at 37C until reaching an OD600 of 0.6–0.7, af-
ter which protein expression induction with 0.1mM IPTG took place for 16 hr at
20C. Afterward, cultures were centrifuged at 3,5003 g for 30 min and the cell
pellets were resuspended in 5 ml of a suitable buffer for each protein (HEPES
[pH 7.5], 300 mM NaCl, 1 mM pyridoxal 50-phosphate (PLP) for VFTA-GFP11;
Tris-HCl [pH 7.5], 300 mM NaCl for GFP11-PLE3; and sodium phosphate
[pH 8.0], 300 mM NaCl for CHMO-GFP11) before cell disruption by sonicationlsevier Ltd All rights reserved
and centrifugation (30 min, 20,000 3 g). The resulting supernatant was em-
ployed as starting material for a standard protein purification by affinity chro-
matography with TALON resin, taking advantage of the presence of a His6 tag
attached to the original proteins of interest (in addition to the recently added
GFP11-tag) and following the supplier’s instructions, adding the required imid-
azole concentrations to the buffers described above.
Microtititer Plate Cultivation
The clones of the epPCR library were picked into 96-well standard SBS MTPs
filled with 200 ml of LB and grown at 37C and 700 rpm for 6 hr in a Thermo
Cytomat 1550 equipped with a shaking unit. Protein expression was induced
with 0.1 mM IPTG for 12 hr at 20C and 700 rpm. The cell suspension
was centrifuged at 4,300 3 g for 20 min and the resulting cell pellets were
washed with HEPES (pH 7.5), 300 mM NaCl, and 1 mM PLP for VFTA-
GFP11, followed by centrifugation at 4,460 3 g for 20 min. Lysis was per-
formed by addition of lysis buffer (1 mg/ml lysozyme and 1 mg/ml DNAase)
in HEPES (pH 7.5), 300 mM NaCl, and 1 mM PLP, and shaking for 2 hr at
30C and 700 rpm. Cell debris was removed by centrifugation (20 min at
4,460 3 g). The resulting supernatant was transferred to a new 96-well MTP
by a pipetting robot. The resulting crude cell lysate was stored at 4C before
enzyme activity tests.
Enzymatic Assays
The activity of the VFTA was determined by the phenylpropan-1-one (3) assay,
using 1 mM (S)-1-phenylpropan-1-amine (1) as amine donor and 2.5 mM py-
ruvate (2) as amine acceptor, in 50 mM CHES buffer (pH 9.0). Alanine is the
resulting amination product (4). Absorption was measured at 245 nm over
15 min with a sampling rate of 1/30 s (see Scheme S1) (Schaetzle et al., 2009).
CHMO activity was measured on the basis of NADPH consumption, em-
ploying as substrates 10 mM cyclohexanone (5) and 0.4 mM NADPH in
50mM sodium phosphate buffer (pH 8.0). NADPH consumption was assessed
by monitoring the absorbance of the reaction mixture at 340 nm over 10 min.
The product is ε-caprolactone (6) (see Scheme S2) (Donoghue et al., 1976).
PLE3 activity was assessed via the p-nitrophenol (8) assay, and performed
employing 10 mM p-nitrophenyl acetate (7) in Tris-HCl buffer (pH 7.5). The
reaction was monitored by absorption measurement at 405 nm for 15 min to
quantify the released p-nitrophenolate (see Scheme S3) (Krebsfa¨nger et al.,
1998).
VFTA Mutant Library Generation and Screening
Using the VFTA-GFP11 gene as template, an epPCRmutant library was gener-
ated employing the GeneMorph II mutagenesis kit (Stratagene). The epPCR
product was incorporated into the original expression construct pRSF-Duet
VFTA-GFP11 by MEGAWHOP (Miyazaki, 2011). 588 clones were picked into
96-well plates and ten of them were randomly selected for sequencing,
revealing an average of 3.7 ± 1.1 point mutations per gene with no detectable
wild-type background.
Screening Process
For the screening process, standard 96-well MTPs (Greiner BioOne) were
used. The absorption measurements for enzymatic activity were performed
in a Thermo Fisher Varioskan microplate reader, while a BMG omega reader
was employed for the optical density measurements of the cell growth. The pi-
petting steps for mixing the assay solutions were supported by an Agilent
Bravo pipetting robot, accessed with a 96-well pipetting head and a pipette
tips wash station.
Data Analysis
Data analysis was automated by scripts (see Supplemental Information) of the
open-source statistical evaluation software package R (version 3.0.2, http://
www.r-project.org) to cope with the large amount of data and to facilitate
the strong data visualization capabilities of R. The results of the activity mea-
surements and fluorescent data were combined in a single overview plot
showing all 96 wells in a single multipanel image (see Figure S5 for an
example). The script calculates the slope for each well, selects the reference
wells (=WT wells), normalizes the enzyme activity by formation of the quotient
between activities and fluorescence for each well (ratio), and finally highlights
the best mutants according to a predefined stringency criteria (e.g. 20%better
than the maximum ratio of the wild-types).Chemistry & Biology 22, 1406–1The latest source code of the R scripts is published under the GPL3 license
and is openly accessible at http://lara.uni-greifswald.de or http://github.com/
markdoerr/lara_dataworkflow/.
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